Technical Analysis for TNXP - Tonix Pharmaceuticals Holding Corp.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Gilligan's Island Sell Setup | Bearish Swing Setup | 2.47% | |
Pocket Pivot | Bullish Swing Setup | 2.47% | |
Volume Surge | Other | 2.47% | |
Wide Range Bar | Range Expansion | 2.47% | |
Wide Bands | Range Expansion | 2.47% | |
Above Upper BB | Strength | 2.47% | |
Gapped Up | Strength | 2.47% | |
Up 3 Days in a Row | Strength | 2.47% | |
Bullish Engulfing | Bullish | 19.67% | |
Crossed Above 20 DMA | Bullish | 19.67% |
Alert | Time |
---|---|
Reversed from Down | about 2 hours ago |
60 Minute Opening Range Breakout | about 2 hours ago |
Possible Pocket Pivot | about 2 hours ago |
Gapped Down (Full) | about 3 hours ago |
2x Volume Pace | about 3 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
Tonix Pharmaceuticals Holding Corp., a development stage specialty pharmaceutical company, focuses on the development of pharmaceutical products for the disorders of central nervous system. The company's lead product candidate includes TNX-102 SL, a dose and formulation of cyclobenzaprine for the treatment of fibromyalgia and post-traumatic stress disorder. It also has a pipeline of various other product candidates, including TNX-201, which is a treatment for certain types of headaches; and TNX-301. The company was founded in 2007 and is headquartered in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Sciences Drugs Pharmaceutical Products Disorders Post Traumatic Stress Disorder Headache Stage Specialty Pharmaceutical Fibromyalgia Seth Lederman
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Sciences Drugs Pharmaceutical Products Disorders Post Traumatic Stress Disorder Headache Stage Specialty Pharmaceutical Fibromyalgia Seth Lederman
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 22.1376 |
52 Week Low | 0.118 |
Average Volume | 35,100,557 |
200-Day Moving Average | 3.59 |
50-Day Moving Average | 0.15 |
20-Day Moving Average | 0.15 |
10-Day Moving Average | 0.15 |
Average True Range | 0.02 |
RSI (14) | 65.64 |
ADX | 19.07 |
+DI | 53.46 |
-DI | 11.90 |
Chandelier Exit (Long, 3 ATRs) | 0.20 |
Chandelier Exit (Short, 3 ATRs) | 0.20 |
Upper Bollinger Bands | 0.18 |
Lower Bollinger Band | 0.12 |
Percent B (%b) | 1.15 |
BandWidth | 41.17 |
MACD Line | 0.00 |
MACD Signal Line | -0.01 |
MACD Histogram | 0.005 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.33 | ||||
Resistance 3 (R3) | 0.34 | 0.31 | 0.31 | ||
Resistance 2 (R2) | 0.31 | 0.27 | 0.30 | 0.30 | |
Resistance 1 (R1) | 0.25 | 0.25 | 0.23 | 0.24 | 0.29 |
Pivot Point | 0.22 | 0.22 | 0.21 | 0.21 | 0.22 |
Support 1 (S1) | 0.16 | 0.18 | 0.14 | 0.14 | 0.09 |
Support 2 (S2) | 0.12 | 0.16 | 0.12 | 0.08 | |
Support 3 (S3) | 0.06 | 0.12 | 0.07 | ||
Support 4 (S4) | 0.05 |